Hypoxemia at rest or during activities is associated with worse prognosis in pulmonary conditions such as COPD and interstitial lung diseases. This study adds IPAH and HPAH to the list.
A 68-year-old man presents with dyspnea on exertion. What caused his left-sided pleural effusion?
Key changes include a higher size threshold for radiographic follow-up; greater flexibility in selecting follow-up interval; and longer duration of radiographic surveillance for suspicious subsolid nodules.
Three articles based on a lecture series originally developed for fellows in pulmonary and critical care medicine to provide them with the tools to transform a scientific or clinical question into research projects, and then pursue the answer to their question with the appropriate methods.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic’s Asthma Center Co-Director addresses the literature examining a possible association between leukotriene-modifying agents like montelukast and suicidality.
In addition to determining the probability of finding N2 or N3 disease on EBUS-TBNA the model is also able to predict the presence of mediastinal disease when EBUS-TBNA nodal sampling is negative.
The potential for molecular biomarkers to tip the balance from benefit to harm in lung cancer screening and nodule diagnosis and to enhance risk prediction warrants a robust discussion about how we determine their accuracy and readiness for clinical use.
Based on our experience at Cleveland Clinic, we favor centralized management of screening decisions in our health system, detailed and thorough shared decision-making visits with one-year follow up and concrete plans for managing incidental findings.
Cleveland Clinic’s Lung and Heart-Lung Transplant Program has gained significant expertise in the management and successful transplantation of recipients who are older than 65, have concomitant CAD or may need liver-lung or heart-lung transplantation. Here we share some recent experiences with these nonconventional transplant recipient cohorts.
The first reported use of tissue plasminogen activator to treat a pregnant patient for a complicated parapneumonic pleural effusion has a successful outcome.